ALLR — Allarity Therapeutics Balance Sheet
0.000.00%
- $20.09m
- $6.72m
- $0.32m
Annual balance sheet for Allarity Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 19.6 | 2.08 | 0.222 | 19.6 | 14.8 |
| Net Total Receivables | 1.34 | 0.871 | 0.946 | 2.23 | 0.895 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21.1 | 4.97 | 1.97 | 22.3 | 17.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.094 | 0.027 | 0.02 | 0.309 | 0.33 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 49.6 | 14.5 | 11.9 | 22.6 | 18.3 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.7 | 11.2 | 14.2 | 10.8 | 8.43 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.8 | 12.7 | 14.6 | 10.8 | 8.43 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 18.8 | 1.89 | -2.75 | 11.8 | 9.83 |
| Total Liabilities & Shareholders' Equity | 49.6 | 14.5 | 11.9 | 22.6 | 18.3 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |